Panel Intelligence will be holding a leadership summit about the Interscience Conference on AntimicrobialAgents and Chemotherapy (ICAAC) which will be held in Chicago from September 17-20, 2007. This onlinepanel discussion will include key opinion leaders in the field of infectious disease who will bediscussing topics related to bacterial resistance and nosocomial (hospital-acquired) infections.Companies and products that are scheduled to be discussed include:

• Arpida's Iclaprim (intravenous and oral formulations)
• Targanta Therapeutic's oritavancin
• Johnson & Johnson's and Basilea Pharmaceutica's ceftobiprole
• Cubist Pharmaceutical's Cubicin® (daptomycin)
• Daiichi Pharmaceutical's sitafloxacin
• Johnson & Johnson/Ortho-McNeil's doripenem
• Replidyne's faropenem
• Sanofi-Aventis' Ketek® (telithromycin)
• Advanced Life Sciences' cethromycin

There will also be a short discussion of the Rotavirus vaccine including Merck's RotaTeq™ as well asGlaxoSmithKline's and AvantImmunotherapeutics' Rotarix™.

To obtain access, please contact:
Sarina Chhay
Sales Support Associate
Panel Intelligence
150 Cambridgepark Drive, 7th Floor
Cambridge, MA 02140
Phone: 617-532-5728
Email: Sarina.chhay@panelintelligence.com